Two-layered dissolving microneedles for percutaneous delivery of sumatriptan in rats

References

• Leonardi M, Steiner TJ, Scher AT, Lipton RB. (2005). The global burden of migraine: Measuring disability in headache disorders with WHO’s Classification of Functioning, Disability and Health (ICF). J Headache Pain, 6:429–440.
   PubMedGoogle Scholar
• Robert E, Ryan JMD. (2001). Patient treatment preferences and the 5-HT1B/1D agonists. Arch Intern Med, 161:2545–2553.
   PubMed Web of Science ®Google Scholar
• Luthringer R, Djupesland PG, Sheldrake CD, Flint A, Boeijinga P, Danjou P et al. (2009). Rapid absorption of sumatriptan powder and effects on glyceryl trinitrate model of headache following intranasal delivery using a novel bi-directional device. J Pharm Pharmacol, 61:1219–1228.
   PubMed Web of Science ®Google Scholar
• Dilone E, Bergstrom D, Cabana B, Nedumpara M, Fox AW; Sumatriptan Lingual Spray Study Group. (2009). Rapid oral transmucosal absorption of sumatriptan, and pharmacodynamics in acute migraine. Headache, 49:1445–1453.
   PubMed Web of Science ®Google Scholar
• Volans GN. (1978). Migraine and drug absorption. Clin Pharmacokinet, 3:313–318.
   PubMed Web of Science ®Google Scholar
• Hussey EK, Aubert B, Richard I, Kunka RL, Fowler P. (1995). The clinical pharmacology of sumatriptan suppositories. Cephalgia, 15 S14: 223.
   Google Scholar
• Rothrock JF. (2010). Injectable sumatriptan: Now needle-based or needle-free: Headache toolbox. Headache, 50:343–344.
   PubMed Web of Science ®Google Scholar
• Brandes JL, Cady RK, Freitag FG, Smith TR, Chandler P, Fox AW et al. (2009). Needle-free subcutaneous sumatriptan (Sumavel DosePro): bioequivalence and ease of use. Headache, 49:1435–1444.
   PubMed Web of Science ®Google Scholar
• Duquesnoy C, Mamet JP, Sumner D, Fuseaud E. (1998). Comparative clinical pharmacokinetics of single doses of sumatriptan following subcutaneous, oral, rectal and intranasal administration. Eur J Pharm Sci, 6:99–104.
   PubMed Web of Science ®Google Scholar
• Patel SR, Zhong H, Sharma A, Kalia YN. (2007). In vitro and in vivo evaluation of the transdermal iontophoretic delivery of sumatriptan succinate. Eur J Pharm Biopharm, 66:296–301.
   PubMed Web of Science ®Google Scholar
• Siegel SJ, O’Neill C, Dubé LM, Kaldeway P, Morris R, Jackson D et al. (2007). A unique iontophoretic patch for optimal transdermal delivery of sumatriptan. Pharm Res, 24:1919–1926.
   PubMed Web of Science ®Google Scholar
• Henry S, McAllister DV, Allen MG, Prausnitz MR. (1998). Microfabricated micropiles: A novel approach to transdermal drug delivery. J Pharm. Sci, 187: 922–925.
   Web of Science ®Google Scholar
• Teo MA, Shearwood C, Ng KC, Lu J, Moochhala S. (2005). In vitro and in vivo characterization of MEMS microneedles. Biomed Microdevices, 7:47–52.
   PubMed Web of Science ®Google Scholar
• Park JH, Allen MG, Prausnitz MR. (2006). Polymer micropiles for control1ed-release drug delivery. Pharm Res, 23:1008–1019.
   PubMed Web of Science ®Google Scholar
• Davis SP, Martanto W, Allen MG, Prausnitz MR. (2005). Hollow metal microneedles for insulin delivery to diabetic rats. IEEE Trans Biomed Eng, 52:909–915.
   PubMed Web of Science ®Google Scholar
• McAllister DV, Wang PM, Davis SP, Park JH, Canatella PJ, Allen MG et al. (2003). Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies. Proc Natl Acad Sci USA, 100:13755–13760.
   PubMed Web of Science ®Google Scholar
• Ito Y, Ohashi Y, Saeki A, Sugioka N, Takada K. (2008). Antihyperglycemic effect of insulin from self-dissolving micropiles in dogs. Chem Pharm Bull, 56:243–246.
   PubMed Web of Science ®Google Scholar
• Ito Y, Hagiwara E, Saeki A, Sugioka N, Takada K. (2006). Feasibility of microneedles for percutaneous absorption of insulin. Eur J Pharm Sci, 29:82–88.
   PubMed Web of Science ®Google Scholar
• Ito Y, Yoshimitsu J, Shiroyama K, Sugioka N, Takada K. (2006). Self-dissolving microneedles for the percutaneous absorption of EPO in mice. J Drug Target, 14:255–261.
   PubMed Web of Science ®Google Scholar
• Ito Y, Shiroyama K, Yoshimitsu J, Ohashi Y, Sugioka N, Takada K. (2007). Pharmacokinetic and pharmacodynamic studies following percutaneous absorption of erythropoietin micropiles to rats. J Control Release, 121:176–180.
   PubMed Web of Science ®Google Scholar
• Ito Y, Saeki A, Shiroyama K, Sugioka N, Takada K. (2008). Percutaneous absorption of interferon-alpha by self-dissolving micropiles. J Drug Target, 16:243–249.
   PubMed Web of Science ®Google Scholar
• Ito Y, Ohashi Y, Shiroyama K, Sugioka N, Takada K. (2008). Self-dissolving micropiles for the percutaneous absorption of recombinant human growth hormone in rats. Biol Pharm Bull, 31:1631–1633.
   PubMed Web of Science ®Google Scholar
• Naito Y, Shin’oka T, Hibino N, Matsumura G, Kurosawa H. (2008). A novel method to reduce pericardial adhesion: A combination technique with hyaluronic acid biocompatible membrane. J Thorac Cardiovasc Surg, 135:850–856.
   PubMed Web of Science ®Google Scholar
• Cheung RY, Ying Y, Rauth AM, Marcon N, Yu Wu X. (2005). Biodegradable dextran-based microspheres for delivery of anticancer drug mitomycin C. Biomaterials, 26:5375–5385.
   PubMed Web of Science ®Google Scholar
• Chen FM, Wu ZF, Sun HH, Wu H, Xin SN, Wang QT et al. (2006). Release of bioactive BMP from dextran-derived microspheres: a novel delivery concept. Int J Pharm, 307:23–32.
   PubMed Web of Science ®Google Scholar
• Takada K. (2008). Microfabrication-derived DDS: From batch to individual production. Drug Discov Ther, 2:140–155.
   PubMedGoogle Scholar
• Tan A, Hang P, Couture J, Hussain S, Vallée F. (2007). An evaporation-free solid-phase extraction method for rapid and accurate analysis of sumatriptan in human plasma by LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci, 856:9–14.
   PubMed Web of Science ®Google Scholar
• Ferrari A, Pinetti D, Bertolini A, Coccia C, Sternieri E. (2008). Interindividual variability of oral sumatriptan pharmacokinetics and of clinical response in migraine patients. Eur J Clin Pharmacol, 64:489–495.
   PubMed Web of Science ®Google Scholar
• Maas HJ, Spruit MA, Danhof M, Della Pasqua OE. (2008). Relevance of absorption rate and lag time to the onset of action in migraine. Clin Pharmacokinet, 47:139–146.
   PubMed Web of Science ®Google Scholar
• Rapoport A, Winner P. (2006). Nasal delivery of antimigraine drugs: clinical rationale and evidence base. Headache, 46 Suppl 4:S192–S201.
   PubMed Web of Science ®Google Scholar
• Pierce M, Marbury T, O’Neill C, Siegel S, Du W, Sebree T. (2009). Zelrix: a novel transdermal formulation of sumatriptan. Headache, 49:817–825.
   PubMed Web of Science ®Google Scholar